REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroendoquito S.A.S. (Ecuador)

Main Activities: Offices of Physicians
Full name: Neuroendoquito S.A.S. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neuroendoquito S.A.S. is a company based in Ecuador, with its head office in Quito. It operates in the Offices of Physicians industry. The enterprise was incorporated on April 13, 2022. It currently has a total number of 3 (2023) employees. There was a net sales revenue increase of 6.7% reported in Neuroendoquito S.A.S.’s latest financial highlights for 2023. Over the same period, its total assets decreased by 59.58%. The enterprise’s net profit margin decreased by 10.59% in 2023.

Headquarters
Calle San Gabriel
Quito; Pichincha;

Contact Details: Purchase the Neuroendoquito S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neuroendoquito S.A.S. report to view the information.
Outstanding Shares:
Purchase the Neuroendoquito S.A.S. report to view the information.
Registered Capital:
Purchase the Neuroendoquito S.A.S. report to view the information.
Incorporation Date:
April 13, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Neuroendoquito S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
6.7%
Total operating revenue
6.7%
Operating profit (EBIT)
-26.85%
Net Profit (Loss) for the Period
-27.42%
Total assets
-59.58%
Total equity
-63.08%
Operating Profit Margin (ROS)
-10.65%
Net Profit Margin
-10.59%
Return on Equity (ROE)
48.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?